🔴 Hims & Hers Health is trading 6.1% down today as it gives back gains from a post-FDA-vote rebound

Hims & Hers Health is trading at €24.36 (-6.09%) as the stock gives back part of the rebound seen on July 27 following a sharp selloff.

• The recent volatility follows a mixed vote by the FDA Pharmacy Compounding Advisory Committee regarding seven peptides that are central to the company’s growth strategy.
• While the broader healthcare sector is firmer, the stock is moving lower alongside a 1.15% decline in the Nasdaq, suggesting risk-off trading in growth names rather than sector-wide weakness.
• There are no new company-specific catalysts reported for July 28, pointing to continued volatility following last week's regulatory developments.